AzTrials
AzTrials

IV Line Placement With UltrasoundNCT06296264

Ultra-portable Ultrasound vs. Standard Ultrasound to Help Place a Peripheral Catheter in Patients at Risk of Difficult Puncture

A study testing Standard ultrasound and Ultra-portable ultrasound in people with IV Line Placement With Ultrasound, run by Centre Hospitalier Saint Joseph Saint Luc de Lyon at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The placement of an intravenous (IV) line is a common procedure when treating adult patients in critical care, in the emergency room or in the operating room. This simple and minimally invasive procedure can sometimes be made difficult depending on the patient's morphology or their clinical condition. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
IV Line Placement With Ultrasound
What is being tested?
Standard ultrasound and Ultra-portable ultrasound
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250 participants
Where
1 siteFrance
Study dates
27 Aug 2024to Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient aged at least 18 years old
  • Patient with an A-DIVA (Adult Difficult Intravenous Access) score > 1
  • Supported by a nurse trained in all the techniques used in the protocol
  • Patient having given free, informed and oral consent -

Who cannot join

  • Patient who has already been included in the study
  • Patient whose inclusion in the study would lead to a delay in treatment
  • Adult patient protected by law
  • Pregnant woman
  • Patient not benefiting from French Social Security system -

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Saint Joseph Saint Luc Hospital

    Lyon, Auvergne-Rhône-Alpes, 69007

    Emmanuel VIVIER, MD, 0033478618209, evivier@saintjosephsaintluc.fr

    Fanny DOROSZEWSKI, Mrs, 0033478618398, fdoroszewski@saintjosephsaintluc.fr

    Recruiting

Other trials in France

About this study

The placement of an intravenous (IV) line is a common procedure when treating adult patients in critical care, in the emergency room or in the operating room. This simple and minimally invasive procedure can sometimes be made difficult depending on the patient's morphology or their clinical condition. The procedure then becomes time-consuming, anxiety-provoking, painful and its success is uncertain.

The placement of intravenous (IV) lines under ultrasound by nurses is a rapidly developing alternative in intensive care, emergencies and the operating room.

Read the detailed description

The main objective is to test the hypothesis that intravenous puncture guided by an ultraportable ultrasound machine is faster than puncture guided by a conventional ultrasound machine.

Being tested
Standard ultrasound, Ultra-portable ultrasound
Keywords
IV line, Ultra-portable ultrasound, Standard ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard ultrasoundDevice

    Placement of IV line using standard ultrasound.

  • Ultra-portable ultrasoundDevice

    Placement of IV line using ultra-portable ultrasound.

Study groups in NCT06296264
Study groupRoleWhat they receive
Standard ultrasoundOtherComparator
Receives: Device: Standard ultrasound
Ultra-portable ultrasoundExperimentalNot described
Receives: Device: Ultra-portable ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intravenous (IV) line placement time

    Time in minutes between tourniquet placement and dressing application after placement.

    Measured: Day 0

Secondary outcomes (9)
  1. Placement of the IV line successfully obtained from the first puncture

    Percentage of cases where the placement of the IV line was obtained from the first puncture

    Measured: 12 months (estimated)

  2. Number of skin perforations

    Number of skin perforations required to establish the IV line

    Measured: Day 0

  3. Overall success rate after 3 punctures

    Overall success rate after 3 punctures

    Measured: Day 0

  4. Use an alternative solution (central catheter)

    Need to use an alternative solution (central catheter)

    Measured: Day 0

  5. Patient satisfaction with IV line placement

    Patient satisfaction with intravenous line placement (assessed by Likert scale)

    Measured: Day 0

  6. Nurse satisfaction with IV line placement

    Nurse satisfaction with intravenous line placement (assessed by Likert scale)

    Measured: Day 0

  7. Immediate complications related to intravenous access

    Number of immediate complications related to intravenous access, including arterial puncture and/or hematoma formation

    Measured: Day 0

  8. Delayed complications related to intravenous access

    Number of delayed complications related to intravenous access, including extravasation and/or the occurrence of infectious thrombophlebitis

    Measured: Day 7

  9. Date of IV line placement and removal

    Delays between IV line placement and removal

    Measured: Day 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2024
  2. Study start27 Aug 2024
  3. Primary completionApr 2025 (estimated)
  4. Study completionSep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06296264
Sponsor's protocol ID
ULTRACATHLON
Status last verified
Oct 2024
First submitted
22 Feb 2024
Last updated
24 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Standard ultrasound and Ultra-portable ultrasound in people with IV Line Placement With Ultrasound, run by Centre Hospitalier Saint Joseph Saint Luc de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intravenous (IV) line placement time (time frame: Day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in